Determinants of long‐term allograft function following steroid withdrawal in renal transplant recipients
- 1 October 1995
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 9 (5) , 419-423
- https://doi.org/10.1111/j.1399-0012.1995.tb00359.x
Abstract
We retrospectively measured changes in serum creatinine concentration as estimates of changes in renal function in 96 renal transplant recipients who were withdrawn from steroid therapy, maintained on cyclosporine and azathioprine, and followed for 1 to 5 years. Multivariate analyses were used to assess the influence of cyclosporine dose and blood levels, azathioprine dose, age, sex, race, diabetes, HLA match and mismatch, PRA, and history of rejection following steroid withdrawal on long‐term allograft function. Results indicate that acute rejection and cyclosporine dose are the major factors influencing long‐term renal function after steroid withdrawal. In this setting, there is an inverse relationship between cyclosporine dose and serum creatinine concentration for up to 5 years. Optimal renal function is achieved in patients receiving more than 5.5 mg/kg of cyclosporine per day at the time of steroid withdrawal.This publication has 17 references indexed in Scilit:
- Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant RecipientsNew England Journal of Medicine, 1994
- WITHDRAWAL OF STEROIDS AFTER RENAL TRANSPLANTATION—CLINICAL PREDICTORS OF OUTCOME1Transplantation, 1992
- Independent Effects of Cyclosporine and Prednisone on Posttransplant HypercholesterolemiaAmerican Journal of Kidney Diseases, 1991
- EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- A PROSPECTIVE RANDOMIZED TRIAL OF PREDNISONE VERSUS NO PREDNISONE MAINTENANCE THERAPY IN CYCLOSPORINE-TREATED AND AZATHIOPRINE-TREATED RENAL TRANSPLANT PATIENTSTransplantation, 1990
- STRATEGIES FOR OPTIMIZING GROWTH IN CHILDREN WITH KIDNEY TRANSPLANTSTransplantation, 1989
- WITHDRAWAL OF STEROID IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988
- COMPLETE REPLACEMENT OF METHYLPREDNISOLONE BY AZATHIOPRINE IN CYCLOSPORINE-TREATED PRIMARY CADAVERIC RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, ILTransplantation, 1988
- The Plasma Creatinine Concentration Is Not an Accurate Reflection of the Glomerular Filtration Rate in Stable Renal Transplant Patients Receiving CyclosporineAmerican Journal of Kidney Diseases, 1987
- THE USE OF CYCLOSPORINE IN LIVING-RELATED RENAL TRANSPLANTATIONTransplantation, 1984